Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 3

Results: 25

PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 843, doi. 10.1007/s00262-021-02849-z

By:

Appleton, Kathryn M.;
Elrod, Ashley K.;
Lassahn, Katy A.;
Shuford, Stephen;
Holmes, Lillia M.;
DesRochers, Teresa M.

Publication type:

Article

High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 831, doi. 10.1007/s00262-020-02769-4

By:

Anghileri, Elena;
Di Ianni, Natalia;
Paterra, Rosina;
Langella, Tiziana;
Zhao, Junfei;
Eoli, Marica;
Patanè, Monica;
Pollo, Bianca;
Cuccarini, Valeria;
Iavarone, Antonio;
Rabadan, Raul;
Finocchiaro, Gaetano;
Pellegatta, Serena

Publication type:

Article

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 857, doi. 10.1007/s00262-020-02738-x

By:

Jiang, Haiping;
Zheng, Yulong;
Qian, Jiong;
Mao, Chenyu;
Xu, Xin;
Li, Ning;
Xiao, Cheng;
Wang, Huan;
Teng, Lisong;
Zhou, Hui;
Wang, Shuyan;
Zhu, Donglei;
Sun, Tao;
Yu, Yingying;
Guo, Wenying;
Xu, Nong

Publication type:

Article

Pembrolizumab and atezolizumab in triple-negative breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 607, doi. 10.1007/s00262-020-02736-z

By:

Kwapisz, Dorota

Publication type:

Article

Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 619, doi. 10.1007/s00262-020-02735-0

By:

Qu, Jingjing;
Mei, Quanhui;
Chen, Lijun;
Zhou, Jianying

Publication type:

Article

Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 773, doi. 10.1007/s00262-020-02733-2

By:

Wen, Di-guang;
Zhao, Xiao-ping;
You, Yu;
Liu, Zuo-jin

Publication type:

Article

Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 817, doi. 10.1007/s00262-020-02732-3

By:

Nishie, Mariko;
Suzuki, Eiji;
Hattori, Masakazu;
Kawaguch, Kosuke;
Kataoka, Tatsuki R.;
Hirata, Masahiro;
Pu, Fengling;
Kotake, Takeshi;
Tsuda, Moe;
Yamaguchi, Ayane;
Sugie, Tomoharu;
Toi, Masakazu

Publication type:

Article

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 763, doi. 10.1007/s00262-020-02730-5

By:

Papadopoulos, Kyriakos P.;
Lakhani, Nehal;
Falchook, Gerald S.;
Riley, Gosia;
Baeck, Johan;
Brown, Karen S.;
Gordon, Gilad;
Le, Lidya;
Wang, Judy S.

Publication type:

Article

Anti-leukemia effect associated with down-regulated CD47 and up-regulated calreticulin by stimulated macrophages in co-culture.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 787, doi. 10.1007/s00262-020-02728-z

By:

Hassan, Eman M.;
Walker, Gilbert C.;
Wang, Chen;
Zou, Shan

Publication type:

Article

Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 803, doi. 10.1007/s00262-020-02727-0

By:

Toor, Salman M.;
Taha, Rowaida Z.;
Sasidharan Nair, Varun;
Saleh, Reem;
Murshed, Khaled;
Abu Nada, Mohamed;
Elkord, Eyad

Publication type:

Article

A systematic scoping review on natural killer cell function in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 597, doi. 10.1007/s00262-020-02721-6

By:

Reid, Fiona S. W.;
Egoroff, Natasha;
Pockney, Peter G.;
Smith, Stephen R.

Publication type:

Article

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 743, doi. 10.1007/s00262-020-02720-7

By:

Chandra, J.;
Woo, W. P.;
Finlayson, N.;
Liu, H. Y.;
McGrath, M.;
Ladwa, R.;
Brauer, M.;
Xu, Y.;
Hanson, S.;
Panizza, B.;
Frazer, I. H.;
Porceddu, Sandro V.

Publication type:

Article

Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survival.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 755, doi. 10.1007/s00262-020-02719-0

By:

Sayed, Heba Abdel Razik;
Hetta, Helal F.;
Shafik, Engy A.;
Zahran, Asmaa M.

Publication type:

Article

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 701, doi. 10.1007/s00262-020-02718-1

By:

Wang, Qinchuan;
Ye, Yuanqing;
Yu, Hao;
Lin, Shu-Hong;
Tu, Huakang;
Liang, Dong;
Chang, David W.;
Huang, Maosheng;
Wu, Xifeng

Publication type:

Article

Varied functions of immune checkpoints during cancer metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 569, doi. 10.1007/s00262-020-02717-2

By:

Safarzadeh, Ali;
Alizadeh, Mohsen;
Beyranvand, Fatemeh;
Falavand Jozaaee, Reza;
Hajiasgharzadeh, Khalil;
Baghbanzadeh, Amir;
Derakhshani, Afshin;
Argentiero, Antonella;
Baradaran, Behzad;
Silvestris, Nicola

Publication type:

Article

Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 689, doi. 10.1007/s00262-020-02715-4

By:

Zhang, Wei;
Lim, Seong-Min;
Hwang, Juyoung;
Ramalingam, Srinivasan;
Kim, Myunghee;
Jin, Jun-O

Publication type:

Article

Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 589, doi. 10.1007/s00262-020-02714-5

By:

Adderley, H.;
Blackhall, F. H.;
Lindsay, C. R.

Publication type:

Article

Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 721, doi. 10.1007/s00262-020-02713-6

By:

Nguyen, Rosa;
Patel, Anand G.;
Griffiths, Lyra M.;
Dapper, Jason;
Stewart, Elizabeth A.;
Houston, Jim;
Johnson, Melissa;
Akers, Walter J.;
Furman, Wayne L.;
Dyer, Michael A.

Publication type:

Article

Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 679, doi. 10.1007/s00262-020-02712-7

By:

Frelau, Alexandra;
Palard-Novello, Xavier;
Jali, Eva;
Boussemart, Lise;
Dupuy, Alain;
James, Pandora;
Devillers, Anne;
Le Jeune, Florence;
Edeline, Julien;
Lesimple, Thierry;
Girard, Antoine

Publication type:

Article

Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 667, doi. 10.1007/s00262-020-02711-8

By:

Yang, Huayu;
Sun, Lejia;
Guan, Ai;
Yin, Huanhuan;
Liu, Meixi;
Mao, Xinxin;
Xu, Haifeng;
Zhao, Haitao;
Lu, Xin;
Sang, Xinting;
Zhong, Shouxian;
Chen, Qian;
Mao, Yilei

Publication type:

Article

Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 657, doi. 10.1007/s00262-020-02709-2

By:

Kijima, Toshiki;
Yamamoto, Hina;
Saito, Kazutaka;
Kusuhara, Shota;
Yoshida, Soichiro;
Yokoyama, Minato;
Matsuoka, Yoh;
Numao, Noboru;
Sakai, Yasuyuki;
Matsubara, Nobuaki;
Yuasa, Takeshi;
Masuda, Hitoshi;
Yonese, Junji;
Kageyama, Yukio;
Fujii, Yasuhisa

Publication type:

Article

Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 869, doi. 10.1007/s00262-020-02708-3

By:

Landsburg, Daniel J.;
Koike, Alexa;
Nasta, Sunita D.;
Svoboda, Jakub;
Schuster, Stephen J.;
Wasik, Mariusz A.;
Caponetti, Gabriel C.

Publication type:

Article

Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 713, doi. 10.1007/s00262-020-02706-5

By:

Xiong, Qi;
Huang, Ziwei;
Xin, Lingli;
Qin, Boyu;
Zhao, Xiao;
Zhang, Jing;
Shi, Weiwei;
Yang, Bo;
Zhang, Guoqing;
Hu, Yi

Publication type:

Article

Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 733, doi. 10.1007/s00262-020-02704-7

By:

Zahran, Asmaa M.;
Hetta, Helal F.;
Mansour, Shimaa;
Saad, Ereny S.;
Rayan, Amal

Publication type:

Article

Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE).

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 633, doi. 10.1007/s00262-020-02692-8

By:

Thakur, Archana;
Kondadasula, Sri Vidya;
Ji, Kyungmin;
Schalk, Dana L.;
Bliemeister, Edwin;
Ung, Johnson;
Aboukameel, Amro;
Casarez, Eli;
Sloane, Bonnie F.;
Lum, Lawrence G.

Publication type:

Article